argyrotsipi/train-dataset huggingface dataset:
Health and Care Bill — House of Lords, 2022-02-09
Topic: Health
Fiona Hodgson (Conservative, Centre-right): My Lords, Amendment 297A is in my name and those of the noble Baronesses, Lady Smith and Lady Cumberlege, but I am also supportive of the other amendments in this group With people living ever longer, looking after older people so that they can stay healthier for longer is critical, as is ensuring that they receive the care they need and have a dignified and secure old age. Amendment 297A seeks to introduce a new clause that will not only lower, from 75 to 65, the age at which every patient is assigned a named GP but sets out to ensure that named GPs will actually have to meet and have some knowledge of each patient they are responsible for, and will communicate directly with them and the family. We need to encourage everyone to take responsibility for their health. Having good and regular health checks is an essential part of the prevention of ill health, as well as leading to earlier identification of conditions and earlier interventions. I am sure that other noble Lords who are doctors will put me right, but I was once told that 65 is an age where things can start to go wrong. Therefore, it is important to start monitoring people’s health and being able to identify changes from this age. This will deliver better outcomes and may also enable people to stay at home and lead a fuller life for longer. The role of the GP in all this is absolutely critical.
Health and Care Bill — House of Lords, 2022-02-09
Topic: Health
Julia Frances Cumberlege (Conservative, Centre-right): I understand that I have overrun so I will say to my noble friends on the Front Bench that we should value general practice. We should build with the best. We should learn from the best. I know that there are hundreds of general practices; it is up to us to applaud them and cherish them and ensure that we see another era of general practice which is different but which values patients and relationship care.
Francis Report: Update and Response — House of Commons, 2015-02-11
Topic: Health
Jeremy Richard Streynsham Hunt (Conservative, Centre-right): My hon. Friend is absolutely right, and I thank him for his interest in his local hospitals and his campaign for them. In the end, culture comes from the top. When people start a job they look at the values of their direct line manager and they copy them, because they think that is what it takes to get on, and the line manager looks to the chief executive and the chief executive in the end looks up to the Secretary of State, so it is very important—[Interruption.] I grant that that may not be the best thing. It is important that right from the top we set the right example about these issues.
Failures of the 111 Helpline — House of Lords, 2016-01-26
Topic: Health
Molly Christine Meacher (Crossbench, Unknown): My Lords, does the Minister agree that this tragic case occurred in an environment of incredible pressure on GPs and others within the NHS, with a growing blame culture and huge numbers of patients—they have to see 60 to 70 in a day very often? We all have to accept that things will go wrong if we leave GPs, in particular, working under those sorts of personal pressures and so on. We know that 30% or so will leave the profession in the coming years. Will the Minister meet with me to discuss what he might do to alleviate some of those problems? That could be very helpful.
Francis Report: Update and Response — House of Commons, 2015-02-11
Topic: Health
Steven John Baker (Conservative, Centre-right): As a former airworthiness engineer, may I strongly endorse my right hon. Friend’s direction of travel? Will he confirm that Buckinghamshire Healthcare NHS Trust, having exited special measures after the Keogh review, has enjoyed a fantastic transformation, which I believe he saw when he visited Wycombe hospital?
European Union (Withdrawal) Bill — House of Lords, 2018-03-14
Topic: Culture
Jane Bonham Carter (Liberal Democrats, Centre to centre-left): My Lords, I rise to add my support to the amendment in the name of the noble Lord, Lord Puttnam, and wish him a speedy recovery. I also speak to the amendment in the name of the noble Lord, Lord Wigley. May I add my thanks for the way in which recent Governments of all hues have got the point of the creative industries and their importance? In my case, it was the late Matthew Evans, Lord Evans of Temple Guiting, who was a Labour Government Minister when I first entered this House. He encouraged me to support and put down debates and Questions on the creative industries—something that I duly did and continue to do. I also add my appreciation for everything that the noble Baroness, Lady Jowell, and the right honourable Ed Vaizey have done to support the sector However, their good work and prescient strategy now risk unravelling. To get to the substantive point of Amendment 146, without some form of reciprocal agreement with the remaining EU member states, our creative and cultural sectors will, as the noble Lord, Lord Puttnam, has said, suffer terrible economic and cultural damage. It is absolutely essential that, as well as being at the heart of the Government’s industrial strategy—which they are—the creative industries are at the top table of Brexit negotiations As the noble Earl, Lord Clancarty, and the noble Lord, Lord Puttnam, have said, many things are crucial to the continuing success of the creative industries—country of origin, IP legislation and collaboration, portability and funding. For example, the British Film Institute distributes around £50 million per annum in lottery funds, but Creative Europe contributes a further £13 million, which would potentially go. Another crucial issue is freedom of movement, which is access not just to international talent, as others have said, but to much-needed skills. Also crucial are the ability for touring performers to cross borders with minimum red tape; design law; and protection from the EU’s cultural exception rules Supporting this vital, vibrant sector is of paramount importance to our economy, to our country’s sense of itself and to our place in the world. Our rich history of cultural exchange must be maintained within Europe. Unless the interests of the creative industries are protected, leaving Europe will be a disaster for a jewel in the crown of our nation. I hope the Minister will accept the amendment.
Topical Questions — House of Commons, 2015-02-12
Topic: Health
Questions: Further to the reply that my hon. Friend the Minister for Culture and the Digital Economy gave a moment ago, can he confirm that the Government’s position remains as set out in the response to the consultation on the review of EU copyright law—that any changes should be based on hard evidence? Perhaps I might ask him a second time to be a little clearer—just so that we can be absolutely certain that everyone is aware—that the Government support the right of territorial licensing, as the Prime Minister’s special adviser set out to the creative industries yesterday.; Many people say that LEPs have been a huge improvement on the regional development agencies, but some small businesses that I talk to in Bristol are concerned that their priorities are not always reflected in local growth funds. Will the Minister work with his colleagues to ensure that the priorities of small businesses are reflected in LEPs, and that LEPs are not unduly influenced by major business interests; The Government have a target, signed off at the highest level, I believe, of achieving £1 trillion of exports by 2020, doubling the current figure in five years. When asked at the Business, Innovation and Skills Committee, a UK Trade & Investment representative described it as an “energising aspiration”. Is it an energising aspiration or is it a realistic, achievable target?; The Minister responsible for life sciences will be familiar with Daiichi Sankyo, an innovative drug company based in Chesham and Amersham. It is launching a novel oral anticoagulant to help prevent strokes more effectively in people who suffer with atrial fibrillation. The uptake of such drugs has been repeatedly blocked by the NHS despite guidance from the National Institute for Health and Care Excellence that calls for their use. What can the Minister do to clear that blockage so that the drugs can be used to benefit our patients?; Ninety-three per cent. of those aged 25 or over who completed apprenticeships last year already worked for their employer. If this is not just a rebadging of existing training programmes as apprenticeships, what is it?
David Willetts (Conservative, Centre-right): Will the Minister confirm that one of the best ways of getting funding into innovative life sciences companies is for them to get contracts from the NHS earlier? He just referred to his very important early access review. What are the ambitions for that, and the timetable?
Topical Questions — House of Commons, 2015-02-12
Topic: Health
Questions: Further to the reply that my hon. Friend the Minister for Culture and the Digital Economy gave a moment ago, can he confirm that the Government’s position remains as set out in the response to the consultation on the review of EU copyright law—that any changes should be based on hard evidence? Perhaps I might ask him a second time to be a little clearer—just so that we can be absolutely certain that everyone is aware—that the Government support the right of territorial licensing, as the Prime Minister’s special adviser set out to the creative industries yesterday.; Many people say that LEPs have been a huge improvement on the regional development agencies, but some small businesses that I talk to in Bristol are concerned that their priorities are not always reflected in local growth funds. Will the Minister work with his colleagues to ensure that the priorities of small businesses are reflected in LEPs, and that LEPs are not unduly influenced by major business interests; The Government have a target, signed off at the highest level, I believe, of achieving £1 trillion of exports by 2020, doubling the current figure in five years. When asked at the Business, Innovation and Skills Committee, a UK Trade & Investment representative described it as an “energising aspiration”. Is it an energising aspiration or is it a realistic, achievable target?; The Minister responsible for life sciences will be familiar with Daiichi Sankyo, an innovative drug company based in Chesham and Amersham. It is launching a novel oral anticoagulant to help prevent strokes more effectively in people who suffer with atrial fibrillation. The uptake of such drugs has been repeatedly blocked by the NHS despite guidance from the National Institute for Health and Care Excellence that calls for their use. What can the Minister do to clear that blockage so that the drugs can be used to benefit our patients?; Ninety-three per cent. of those aged 25 or over who completed apprenticeships last year already worked for their employer. If this is not just a rebadging of existing training programmes as apprenticeships, what is it?
George William Freeman (Conservative, Centre-right): My right hon. Friend and predecessor makes an important point. Since we launched the life science strategy at the start of this Parliament, as set out and led by my right hon. Friend, this country has attracted over £3.5 billion of inward investment into the sector and created more than 11,000 jobs, so something is going very right. He makes a key point: the next step is to ensure that our NHS is driving quicker access. We shall shortly be announcing the chair of the review, and we have already started to gather evidence. My right hon. Friend will have noticed on his recent trip to America the support and the interest that it is gaining overseas for driving our sector forward.
Syria — House of Lords, 2018-04-16
Topic: Defense
Kishwer Falkner (Liberal Democrats, Centre to centre-left): My Lords, this is a sober moment for this country because, although we are extremely relieved that the operation has been successful, we have not seen the threatened Russian retaliation yet, so the game is not over and it is time to reflect a little bit. I am concerned that the Statement repeated here said two things. One was that speed was essential, yet we took seven days. The definition of an emergency is a serious, unexpected and often dangerous situation demanding immediate action. The second thing we have been told today is that the House of Commons is not to be trusted. Despite assurances given by Mr Hague in 2011 and the assurances Mr Cameron gave after the Chilcot report in 2016, when he repeatedly told the other place that it would be extremely exceptional that the convention that had been agreed and established in both Houses would be disregarded, this week that convention has been disregarded. The Minister may know that I had a Private Member’s Bill to codify a war powers Act that would have allowed this action to go ahead had it been codified. Will the Government now go back and contemplate resolving this once and for all?
Gene Editing — House of Lords, 2020-01-30
Topic: Health
Joan Bakewell (Labour, Centre-left): My Lords, when I proposed this debate, I knew that it would be a good one because, as the noble Baroness, Lady Bottomley, said, people in this House know stuff. It has been great to hear so many different points of view Speaking personally, it is rare to find myself in agreement with two bishops—an agreement that I wholly endorse. I have learned a great deal not only from the medical people here but about sport—perhaps, for me, the most surprising entry to this field of knowledge. I very much enjoyed and found interesting what turned out to be a spat about EU regulations between two of the speakers, but I suppose that we are all getting a little twitchy as we get towards the end of tomorrow It has also become clear that the dilemmas are proliferating—the moral dilemmas about children born with genetic diseases, the sport issues, which have not surfaced in my knowledge, and the Government’s ambitious plans for the genome sequencing of children. I think that there is a big issue around that that will be problematic. Finally, I thank the Minister for his answers. He did not propose a strategy for making these issues more possible and more widely acknowledged by the public at large. I hope that that will happen some time soon. In the meantime, I thank him and all noble Lords for taking part.
Medicines and Medical Devices Bill — House of Commons, 2020-03-02
Topic: Health
Philippa Whitford (Scottish National Party, Centre-left): I do not recognise the Secretary of State’s description that it was not possible to inform NHS bodies of concerns about machinery or devices. In my 33 years on the frontline, we received daily information about anything that was considered a danger or a failing, so I do not recognise that.
Medicines and Medical Devices Bill — House of Commons, 2020-03-02
Topic: Health
Philippa Whitford (Scottish National Party, Centre-left): That might well be the case with gadgets, devices or new digital apps, but with new drugs, it is usually the clinicians who are desperate to get their hands on them. Most new drugs, particularly for challenging conditions such as cancer, are expensive and it will be several years before they are passed by NICE in England or the Scottish Medicine Consortium. The delay is not the clinicians not wanting access; it is the cost of introducing them.
Medicines and Medical Devices Bill — House of Commons, 2020-03-02
Topic: Health
Philippa Whitford (Scottish National Party, Centre-left): The Bill is necessary because of Brexit, as the UK is losing the European Medicines Agency—one of the great advantages was working together to have a single licensing system that licensed new drugs right across Europe. As the hon. Member for Bolton West (Chris Green) described, it is about working with other countries to avoid duplication and to speed up getting new drugs from the laboratory to patients who need them The problem is that manufacturers will have to apply separately to the UK, which means extra processes and additional costs. It is important, therefore, that whatever system is adopted is as similar to the EU as possible and does not ask for a whole different set of work-up, investigation and paperwork, or that will put manufacturers off launching their drugs in the UK. The same issues apply to veterinary medicines, hence they are in the Bill The simple fact is that the EU is a market of 500 million people—a quarter of the world pharmaceutical market. The UK on its own is only 3%, which is why drugs tend to be launched in the US and Europe at the same time. In all my 33 years on the frontline, I saw an acceleration of drugs getting from the bench top to the patient, because of the EU and the European Medicines Agency. This means that there are likely to be delays for patients. Canada and Australia wait another six to 12 months before drugs are launched there, so how will the Government avoid a delay in patient access, particularly for new drugs from outside the UK and for conditions such as cancer, where patients are literally waiting for the drug?
Engagements — House of Commons, 2015-02-25
Topic: Defense
David William Donald Cameron (Conservative, Centre-right): At the end of this Parliament, I believe that Government Members can be proud of the fact that we closed the massive black hole in our defence budget left by Labour. We can be proud of the fact that we see Voyager airplanes flying out of Brize Norton. We can be proud of the fact that we are building two aircraft carriers. We can be proud of the fact that we have got the Type 45 destroyers. We can be proud of the fact that submarines are rolling out of the hon. Gentleman’s constituency and into the seas of the Atlantic to keep our country safe.
Cultural Objects (Protection from Seizure) Bill — House of Lords, 2022-04-25
Topic: Culture
Stephen Parkinson (Conservative, Centre-right): My Lords, I am very grateful to my noble friend not just for bringing forward this Bill but for his kind words. I would like to take this opportunity to congratulate Sonia Boyce, who represented the United Kingdom at the UK Pavilion at the Venice Biennale, as well as Emma Ridgway, the curator, and everyone at the British Council who commissioned her work, which I am very pleased to report won the coveted Golden Lion for the first time since 1993. It is a tremendous achievement and everyone in the UK is very proud of them all I am pleased to reiterate the support of Her Majesty’s Government for this Bill. It is short and straightforward but will be of great benefit to the many approved museums and galleries in England and Scotland that rely on immunity from seizure protection when they borrow cultural objects from abroad. It will add an appropriate layer of flexibility to the existing legislation covering immunity from seizure. Currently, as my noble friend says, the maximum length of time an object can be protected from seizure while on loan is 12 months. As we learn and move on from the unprecedented challenges that museums and galleries have faced over the past two years in particular, the Bill rightly recognises that unpredictable delays do sometimes happen and that it may not always be possible for objects to be returned within that existing timeframe. The ability to extend the protection afforded to cultural objects is a sensible option to have. I am very grateful to my noble friend for presenting these helpful measures and for all his work in guiding the Bill through your Lordships’ House, to all noble Lords who have supported it, from all corners of the House, and, as my noble friend says, to the DCMS officials who have supported it As my noble friend says, the guidance for approved museums and galleries on how and when to apply for an extended period of protection has now been published in draft. The policy is therefore ready to be put into effect, subject to Royal Assent being granted. I am grateful to all those who helped the Bill speed on its way to the statute book.
European Union (Withdrawal) Bill — House of Lords, 2018-02-26
Topic: Health
Judith Anne Jolly (Liberal Democrats, Centre to centre-left): We have a window of about two years in which to get this right. I was talking to the trade bodies for over-the-counter medicine last week and they were saying that a change to make all over-the-counter medicines UK-based would need about a five-year timescale. It is just not doable, so there is an absolute imperative to get these regulations sorted out in pretty short order.
GP Appointments — House of Commons, 2020-03-10
Topic: Health
Martyn Day (Scottish National Party, Centre-left): Last year, 85% of doctors surveyed by British Medical Association Scotland said that the pension taxation crisis would have a significant effect on NHS services, such as through waiting times. The Government’s proposal to raise the taper threshold to £150,000 does not fully solve the problem and would cost the Treasury more than it would to reverse the policy, so what is the Minister doing to address the issue?
European Union (Withdrawal) Bill — House of Lords, 2018-02-26
Topic: Defense
Menzies Campbell (Liberal Democrats, Centre to centre-left): We have, effectively, a willing buyer and a willing seller when it comes to security and defence. Why not take the opportunity of concluding that bargain? It would be much easier to do than, for example, the trade agreements that we hope to deal with in the future.
Service Personnel (Ukraine) — House of Commons, 2015-02-25
Topic: Defense
Michael Fallon (Conservative, Centre-right): I agree with my predecessor but one as Secretary of State. We are supplying defensive equipment. It might not be lethal, but it does help the Ukrainian armed forces better defend themselves. As I said in my initial statement, in addition to the secondment of 75 trainers we are considering a further request from the Ukrainian Government for additional equipment and support. That is non-lethal, but we reserve the right ultimately to keep it under review.
Service Personnel (Ukraine) — House of Commons, 2015-02-25
Topic: Defense
Michael Fallon (Conservative, Centre-right): It is slightly unfortunate that the hon. Lady has compared the general purpose force we were attempting to train—a very raw force of recruits from Libya—with the Ukrainian armed forces. She asked me a straightforward and quite reasonable question about where else the training might be. There will be, and has already been, some training in the UK, but there can also be training in countries alongside Ukraine. We are looking at where the training can best be provided, but it is likely that most of it will be provided in Ukraine, in the Kiev area or elsewhere in the west of Ukraine, areas that are very familiar to the British military as we have been on exercise there in the past.
Service Personnel (Ukraine) — House of Commons, 2015-02-25
Topic: Defense
James Whiteside Gray (Conservative, Centre-right): It is of course very important that there should be non-lethal support and training, but in a parallel situation in north-east Iraq, where we are training the peshmerga in Kurdistan, we have discovered that the Americans and other EU allies are training on the front line and they find that much more effective than the kind of training we have been providing about 100 miles behind the front line. Is there not an argument that, although that support is non-lethal, we might find a way to move the troops forward so that they can advise the Ukrainians where they are doing the fighting?
Service Personnel (Ukraine) — House of Commons, 2015-02-25
Topic: Defense
Michael Fallon (Conservative, Centre-right): I do not think it is right for other countries to get involved in the conflict in eastern Ukraine. On the contrary, Russia should now be withdrawing its heavy weapons from eastern Ukraine and be putting pressure on the separatists to lay down their arms. On the location of the training, we are not putting combat troops anywhere near the front line. The training we have been providing to the peshmerga in northern Iraq has, as my hon. Friend says, been well away from the front line. We have trained more than 1,000 peshmerga as well as supplying them with machine guns and ammunition.